FROM THE EDITORS
Welcome to the new HR+ HER2- Breast Cancer Resource Center! We’re excited to present you with current information, news items, highlights from the literature, and other resources that focus on this disease space and the advanced practitioner’s role in delivering high-quality care to patients. If you have any feedback or questions, please contact jadpro-editor@conexiant.com.
Christine McGinn, MSN, APRN, ACNP-BC |
Kate Taucher, PharmD, MHA, BCOP, FASHP, FAPO, FHOPA |
Resources
Clinical Management of Patients Taking Abemaciclib
Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update
HER2 Testing in Breast Cancer - 2023 Guideline Update
News & Literature Highlights